Background and Objective: Tattoo ink stock products often contain potential carcinogens, which on large-scale population exposure may be clinically relevant. The aim of this autopsy study in mice was to screen major organs for clinical and subclinical cancers. Methods: Mice were tattooed on their backs. In total, 48 mice were included and divided into 4 groups; 11 mice tattooed black, 10 tattooed red, and 5 mice serving as untreated controls. A group of 22 mice with black tattoos and exposed to ultraviolet radiation (UVR) were also studied. The black and red inks were both stock products banned on the Danish market due to the measured contents of potential carcinogens; benzo(a)pyrene and 2-anisidine, respectively. The mice were housed for 1 year after tattooing, and autopsy study on internal organs was performed. Tissue samples were systematically taken from major organs for screening of subclinical changes, not detected by visual examination. Any observed deviation from normal structure was subject to biopsy and light microscopy. Results: All mice survived the 1-year observation period. Autopsy revealed no macroscopic signs of cancer. Microscopic search of internal organs showed no subclinical or clinical cancer. Conclusion: Despite extensive tattoos with 2 banned inks, the long-term observation in mice showed no internal cancers nor was the combination of carcinogen and UVR associated with cancer. Lack of observed malignancy might be explained by the fact that tattooing is only a single dose exposure. Registered data on carcinogens relies on repeated or chronic exposures. The study does not support the hypothesis that tattooing causes cancer.

Council of Europe: Resolution ResAP(2003)2) (on requirements and criteria for the safety of tattoos and permanent make-up). (accessed January 10, 2017).
Council of Europe: Resolution ResAP(2008)1 on requirements and criteria for the safety of tattoos and permanent make-up (superseding Resolution ResAP(2003)2 on tattoos and permanent make-up). 2008. (accessed January 10, 2017).
Laux P, Luch A: The European landscape of national regulations of tattoo inks and businesses. Curr Probl Dermatol 2015;48:196-200.
Renzoni A, Pirrera A, Novello F, Diamante MS, Guarino C: Implementation of European Council resolution ResAP(2008)1 in Italy. National and regional regulation of tattoo practices: diversity and challenges. Curr Probl Dermatol 2015;48:201-205.
Jacobsen E, Tønning K, Pedersen E, Bernth N, Serup J, Høgsberg T, Nielsen E: Chemical Substances in Tattoo Ink. (accessed January 10, 2017).
Engel E, Vasold R, Santarelli F, Maisch T, Gopee NV, Howard PC, Landthaler M, Bäumler W: Tattooing of skin results in transportation and light-induced decomposition of tattoo pigments - a first quantification in vivo using a mouse model. Exp Dermatol 2010;19:54-60.
Engel E, Spannberger A, Vasold R, König B, Landthaler M, Bäumler W: Photochemical cleavage of a tattoo pigment by UVB radiation or natural sunlight. J Dtsch Dermatol Ges 2007;5:583-589.
Cui Y, Spann AP, Couch LH, Gopee NV, Evans FE, Churchwell MI, Williams LD, Doerge DR, Howard PC: Photodecomposition of pigment yellow 74, a pigment used in tattoo inks. Photochem Photobiol 2004;80:175-184.
Lerche CM, Sepehri M, Serup J, Poulsen T, Wulf HC: Black tattoos protect against UVR-induced skin cancer in mice. Photodermatol Photoimmunol Photomed 2015;31:261-268.
Sepehri M, Sejersen T, Qvortrup K, Lerche CM, Serup J: Tattoo pigments are observed in the Kupffer cells of the liver indicating blood-borne distribution of tattoo ink. A one-year autopsy study of mice tattooed with black and red tattoo ink products. Dermatology 2017, DOI: 10.1159/000468149.
Wester PW, Muller JJ, Slob W, Mohn GR, Dortant PM, Kroese ED: Carcinogenic activity of benzo[a]pyrene in a 2 year oral study in Wistar rats. Food Chem Toxicol 2012;50:927-935.
Jacobsen NR, Møller P, Jensen KA, Vogel U, Ladefoged O, Loft S, Wallin H: Lung inflammation and genotoxicity following pulmonary exposure to nanoparticles in ApoE-/- mice. Part Fibre Toxicol 2009;6:2.
Lerche CM, Heerfordt IM, Serup J, Poulsen T, Wulf HC: Red tattoos do not protect against UVR-induced skin cancer in mice. Exp Dermatol, in press.
IARCH Monograph: Evaluation of carcinogenic risks to humans. Some non-heterocyclic polycyclic aromatic hydro-carbons and some related exposures. 2010. (accessed January 10, 2017).
National Toxicology Program: Bioassay of o-anisidine hydrochloride for possible carcinogenicity. Natl Cancer Inst Carcinog Tech Rep Ser 1978;89:1-149.
Gopee NV, Cui Y, Olson G, et al: Response of mouse skin to tattooing: use of SKH-1 mice as a surrogate model for human tattooing. Toxicol Appl Pharmacol 2005;209:145-158.
Kluger N, Koljonen V: Tattoos, inks, and cancer. Lancet Oncol 2012;13:e161-e168.
Serup J, Sepehri M, Hutton Carlsen K: Classification of tattoo complications in a hospital material of 493 adverse events. Dermatology 2016;232:668-678.
Maughan WZ, Muller SA, Perry HO, Pittelkow MR, O'Brian PC: Incidence of skin cancers in patients with atopic dermatitis treated with ocal tar. A 25-year follow-up study. J Am Acad Dermatol 1980;3:612-615.
Pittelkow MR, Perry HO, Muller SA, Maughan WZ, O'Brian PC: Skin cancer in patients with psoriasis treated with coal tar. A 25-year followup study. Arch Dermatol 1981;117:465-468.
Roelofzen JH, Aben KK, Oldenhof UT, Coenraads PJ, Alkemade HA, van de Kerkhof PC, van der Valk PG, Kiemeney LA: No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema. J Invest Dermatol 2010;130:953-961.
Marston CP, Pereira C, Ferguson J, et al: Effect of a complex environmental mixture from coal tar containing polycyclic aromatic hydrocarbons (PAH) on the tumor initiation, PAH-DNA binding and metabolic activation of carcinogenic PAH in mouse epidermis. Carcinogenesis 2001;22:1077-1086.
Sapota A, Czerski B, Jedrzejczak M: Tissue distribution, excretion and metabolism of o-anisidine in rats. Int J Occup Med Environ Health 2003;16:351-357.
Serup J, Linnet JT, Olsen O: Tattoos - health, risk and culture. The Council of Health and Disease Prevention. Download, English version. (accessed January 10, 2017).
JRC Technical Reports: Safety of tattoos and permanent make-up. Adverse health effects and experience with the Council of Europe Resolution (2008)1. (accessed January 10, 2017).
JRC Science for Policy Report: Safety of tattoos and permanent make-up. Final report. (accessed January 10, 2017).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.